Pramlintide Acetate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Pramlintide Acetate Injection (injection) from AstraZeneca AB with status No longer listed by FDA. The shortage was first posted on Oct 27, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- AstraZeneca AB
- Package NDC
- 0310-6615-02
- Dosage Form
- Injection
- Presentation
- SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02)
- Initial Posting
- Oct 27, 2025